Log in
NYSE:NNVC

NanoViricides Stock Forecast, Price & News

$3.88
-0.02 (-0.51 %)
(As of 10/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.80
Now: $3.88
$3.92
50-Day Range N/A
52-Week Range
$1.85
Now: $3.88
$19.20
Volume81,900 shs
Average Volume2.09 million shs
Market Capitalization$41.34 million
P/E RatioN/A
Dividend YieldN/A
Beta0.66
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone203-937-6137
Employees17

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.76 per share

Profitability

Net Income$-8,420,000.00

Miscellaneous

Market Cap$41.34 million
Next Earnings DateN/A
OptionableOptionable
$3.88
-0.02 (-0.51 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NNVC News and Ratings via Email

Sign-up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NanoViricides (NYSE:NNVC) Frequently Asked Questions

Who are some of NanoViricides' key competitors?

Who are NanoViricides' key executives?

NanoViricides' management team includes the following people:
  • Dr. Anil R. Diwan, Exec. Chairman, Pres, Acting CEO & Sec. (Age 61, Pay $400k)
  • Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA, Chief Financial Officer (Age 61, Pay $154.09k)
  • Dr. Irach B. Taraporewala, Consultant (Age 64, Pay $419.48k)
  • Dr. Randall W. Barton Ph.D., Chief Scientific Officer & Chief Regulatory Officer (Age 73)

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE) under the ticker symbol "NNVC."

How do I buy shares of NanoViricides?

Shares of NNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $3.88.

How big of a company is NanoViricides?

NanoViricides has a market capitalization of $41.34 million. NanoViricides employs 17 workers across the globe.

What is NanoViricides' official website?

The official website for NanoViricides is www.nanoviricides.com.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Drive, Shelton CT, 06484. The company can be reached via phone at 203-937-6137 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.